2,4-Dinitrophenol

2,4-Dinitrophenol

SCHEMBL7030615

O=[N+]([O-])c1ccc(O)c([N+](=O)[O-])c1.O=[N+]([O-])c1cccc(O)c1[N+](=O)[O-]

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR35 Q9HC97 5/20 0.72
ALDH1A1 P00352 4/20 0.72
TSHR P16473 4/20 0.72
MAPK1 P28482 3/20 0.72
HPGD P15428 2/20 0.72
TP53 P04637 1/20 0.72
SMN1; SMN2 Q16637 1/20 0.72
ALOX15 P16050 3/20 0.47
HSD17B10 Q99714 2/20 0.47
GAA P10253 1/20 0.47
THRB P10828 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
TDP1 Q9NUW8 2/20 0.46
ERN1 O75460 1/20 0.45
ALDH5A1 P51649 1/20 0.45
ABAT P80404 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2,4-Dinitrophenol SCHEMBL27991650 0.98 GPR35 (0.70) GPR35ALDH1A1TSHRMAPK1HPGD
SCHEMBL8959273 0.88 GPR35 (0.72) GPR35ALDH1A1TSHRMAPK1HPGD
2,4-Dinitrophenol SCHEMBL27564362 0.87 GPR35 (0.66) GPR35ALDH1A1TSHRMAPK1HPGD
2,4-Dinitrophenol SCHEMBL28256921 0.87 GPR35 (0.66) GPR35ALDH1A1TSHRMAPK1HPGD
Trinitrophenol SCHEMBL10727440 0.86 GPR35 (0.74) GPR35ALDH1A1TSHRMAPK1HPGD
2,4-Dinitrophenol SCHEMBL5866337 0.85 GPR35 (0.79) GPR35ALDH1A1TSHRMAPK1HPGD
2,4-Dinitrophenol SCHEMBL16980 0.85 GPR35 (0.52) GPR35ALDH1A1TSHRMAPK1HPGD
2,4-Dinitrophenol SCHEMBL27905661 0.85 ALDH1A1 (0.85) GPR35ALDH1A1TSHRMAPK1HPGD
Trinitrophenol SCHEMBL9314438 0.85 GPR35 (0.68) GPR35ALDH1A1TSHRMAPK1HPGD
SCHEMBL29516730 0.85 GPR35 (1.00) GPR35ALDH1A1TSHRMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030045556-A1 Aryl-N-cyanoguanidines and methods related thereto MITOKOR (US) 2003-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030045556-A1 Aryl-N-cyanoguanidines and methods related thereto COX5A, COX5B, MT-CO1 GPR35 611/4885ALDH1A1 320/4885TSHR 3091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.